These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2115629

  • 1. Interaction of intravenous methylprednisolone with oral cyclosporin.
    Ubhi CS, Woodhouse L, Giles GR.
    Nephrol Dial Transplant; 1990; 5(5):376-8. PubMed ID: 2115629
    [Abstract] [Full Text] [Related]

  • 2. Is there a therapeutic range for monitoring plasma cyclosporin in renal allograft recipients?
    Ubhi CS, Woodhouse L, Guillou PJ, Giles GR.
    Nephrol Dial Transplant; 1988; 3(6):814-9. PubMed ID: 3147426
    [Abstract] [Full Text] [Related]

  • 3. Interaction of intravenous methylprednisolone with oral CsA.
    Huisman RM, van Son WJ, Tegzess AM.
    Nephrol Dial Transplant; 1990; 5(10):905-6. PubMed ID: 2128394
    [No Abstract] [Full Text] [Related]

  • 4. Low-dose vs high-dose intravenous methylprednisolone therapy for acute renal allograft rejection in patients receiving cyclosporin therapy.
    Lui SF, Sweny P, Scoble JE, Varghese Z, Moorhead JF, Fernando ON.
    Nephrol Dial Transplant; 1989; 4(5):387-9. PubMed ID: 2505189
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporine A monitoring by radioimmunoassay (RIA) and high-performance liquid chromatography (HPLC) after liver transplantation: influence of route of administration and of liver function on the RIA:HPLC ratio.
    Oldhafer KJ, Schumann G, Wonigeit K, Oellerich M, Ringe B, Pichlmayr R.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):361-5. PubMed ID: 3291268
    [No Abstract] [Full Text] [Related]

  • 6. Blood cyclosporin concentrations and renal allograft dysfunction.
    Holt DW, Marsden JT, Johnston A, Bewick M, Taube DH.
    Br Med J (Clin Res Ed); 1986 Oct 25; 293(6554):1057-9. PubMed ID: 3094774
    [Abstract] [Full Text] [Related]

  • 7. Clinical pharmacokinetics of cyclosporin.
    Ptachcinski RJ, Venkataramanan R, Burckart GJ.
    Clin Pharmacokinet; 1986 Oct 25; 11(2):107-32. PubMed ID: 3514043
    [Abstract] [Full Text] [Related]

  • 8. Concomitant administration of cyclosporin and ketoconazole in renal transplant recipients.
    First MR, Schroeder TJ, Weiskittel P, Myre SA, Alexander JW, Pesce AJ.
    Lancet; 1989 Nov 18; 2(8673):1198-201. PubMed ID: 2572912
    [Abstract] [Full Text] [Related]

  • 9. Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal-transplant recipients.
    Taube DH, Neild GH, Williams DG, Cameron JS, Hartley B, Ogg CS, Rudge CJ, Welsh KI.
    Lancet; 1985 Jul 27; 2(8448):171-4. PubMed ID: 2862369
    [Abstract] [Full Text] [Related]

  • 10. High dose methylprednisolone increases plasma cyclosporin levels in renal transplant recipients.
    Klintmalm G, Säwe J.
    Lancet; 1984 Mar 31; 1(8379):731. PubMed ID: 6143058
    [No Abstract] [Full Text] [Related]

  • 11. Cyclosporine--high-dose steroid interaction in renal transplant recipients: assessment by HPLC.
    Ptachcinski RJ, Venkataramanan R, Burckart GJ, Hakala TR, Rosenthal JT, Carpenter BJ, Taylor RJ.
    Transplant Proc; 1987 Feb 31; 19(1 Pt 2):1728-9. PubMed ID: 3274417
    [No Abstract] [Full Text] [Related]

  • 12. Cyclosporine blood concentrations in the management of renal transplant recipients.
    Rogerson ME, Marsden JT, Reid KE, Bewick M, Holt DW.
    Transplantation; 1986 Feb 31; 41(2):276-8. PubMed ID: 3511588
    [No Abstract] [Full Text] [Related]

  • 13. Cyclosporine and metabolites in blood from renal allograft recipients with nephrotoxicity, rejection, or good renal function: comparative high-performance liquid chromatography and monoclonal radioimmunoassay studies.
    Rosano TG, Pell MA, Freed BM, Dybas MT, Lempert N.
    Transplant Proc; 1988 Apr 31; 20(2 Suppl 2):330-8. PubMed ID: 3284076
    [No Abstract] [Full Text] [Related]

  • 14. Cyclosporin A: correlation between HPLC and RIA serum levels.
    Abisch E, Beveridge T, Gratwohl A, Niederberger W, Nussbaumer K, Schaub P, Speck B, Trapp M.
    Pharm Weekbl Sci; 1982 Jun 25; 4(3):84-6. PubMed ID: 7110912
    [Abstract] [Full Text] [Related]

  • 15. Monitoring cyclosporin concentrations in marrow transplant recipients: comparison of two assay methods.
    Yee GC, Kennedy MS, Gmur DJ, Self SG, Deeg HJ.
    Bone Marrow Transplant; 1987 Feb 25; 1(3):289-95. PubMed ID: 3332139
    [Abstract] [Full Text] [Related]

  • 16. Conversion from cyclosporin to azathioprine 3 months after renal transplantation--is it safe?
    Cassidy MJ, Irving E, Swanepoel CR, Pascoe MD, van Zyl-Smit R, Jacobson JE.
    S Afr Med J; 1986 Sep 13; 70(6):317-8. PubMed ID: 3529454
    [Abstract] [Full Text] [Related]

  • 17. Cyclosporin in renal transplantation in children.
    Klare B, von Walter J, Hahn H, Emmrich P, Land W.
    Lancet; 1984 Sep 22; 2(8404):692. PubMed ID: 6147709
    [No Abstract] [Full Text] [Related]

  • 18. [Use of intravenous cyclosporin in the treatment of episodes of irreversible rejection in renal transplantation].
    Morales J, Mocarquer A, James E, Aris L, Herrera L, Morales I.
    Rev Med Chil; 1987 Dec 22; 115(12):1172-5. PubMed ID: 3332925
    [No Abstract] [Full Text] [Related]

  • 19. Gel chromatographic analysis of cyclosporin and its metabolites in human blood compartments.
    Kodobayashi M, Yamamoto K, Takahara S, Okuyama A, Takashima N, Sawada M, Yanaihara C, Kurokawa N.
    J Pharm Pharmacol; 1995 Aug 22; 47(8):693-7. PubMed ID: 8583375
    [Abstract] [Full Text] [Related]

  • 20. Cyclosporin-erythromycin interaction in renal transplant patients.
    Gupta SK, Bakran A, Johnson RW, Rowland M.
    Br J Clin Pharmacol; 1989 Apr 22; 27(4):475-81. PubMed ID: 2655690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.